Global Swine Pseudorabies Vaccine Market Growth 2025-2031

The global Swine Pseudorabies Vaccine market size is predicted to grow from US$ 622 million in 2025 to US$ 798 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031.

Biological products for preventing pseudorabies in pigs

The growth and development of the swine industry, especially in regions with high pork consumption, has boosted the demand for porcine pseudorabies vaccine. As hog production expands to meet the growing demand for pork products, the need for effective disease prevention measures, including vaccination, becomes more important, which is driving the porcine pseudorabies vaccine market.

LP Information, Inc. (LPI) ' newest research report, the “Swine Pseudorabies Vaccine Industry Forecast” looks at past sales and reviews total world Swine Pseudorabies Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Swine Pseudorabies Vaccine sales for 2025 through 2031. With Swine Pseudorabies Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Pseudorabies Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Swine Pseudorabies Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Pseudorabies Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Pseudorabies Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Pseudorabies Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Pseudorabies Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Swine Pseudorabies Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Swine Pseudorabies Vaccine , Live
Swine Pseudorabies　Vaccine, Inactivated

Segmentation by Application:
Farms
Individual

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Keqian Biology
Zybio
Jinyu Biology
Cahic
Pulike Biology
Hayao
Qilu Animal Protection
Dahuanong
Huapai Biotechnology
Sinopharm Animal Health
Tecon
Zoetis
Boehringer Ingelheim
Bayer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Swine Pseudorabies Vaccine market?

What factors are driving Swine Pseudorabies Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Swine Pseudorabies Vaccine market opportunities vary by end market size?

How does Swine Pseudorabies Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.